ATLANTA, April 28, 2004 (PRIMEZONE) -- Market-Pulse.com is pleased to introduce our featured stock, Pluristem Life Systems, Inc. (OTCBB:PLRS), to the investment community! Pluristem, a biotechnology company, is new to Market-Pulse.com and is poised to become a significant player in stem cell expansion technology! Pluristem just had excellent news out before today's opening bell. Watch this stock move! Other notable stocks that look great lately from a fundamental and technical perspective are:
JDS Uniphase Corp. (Nasdaq:JDSU) : Market Underperform
Ambient Corp. (OTCBB:ABTG) : Attractive
Pfizer Inc. (NYSE:PFE) : Hold
Recommendation Meanings
These recommendations are investment opinions of Market-Pulse.com and reflect the stock's potential to move over the next one to four weeks of trading. This analysis is done from a technical and fundamental perspective.
After Tuesday's Bell Market Commentary
The Dow Jones Industrial Average closed up 33.43 points at 10,478.16, after gaining 92 points earlier in the day. The Nasdaq Composite Index shed 4.24 to 2,032.53 and the S&P 500-stock index tacked on 2.62 to 1,138.15.
About Market-Pulse.com
Market Pulse is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. Market Pulse is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. Market Pulse's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. Market Pulse provides investors with a complete suite of online interactive financial data and tools that includes quotes, charts, company profiles, news, market commentary and SEC filings, just to name a few. Market Pulse offers a free financial newsletter. To subscribe or get more information, visit our home page located at www.market-pulse.com.
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties, disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis.
Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated in free trading shares of common stock, available for public trading as follows: Pluristem Life Systems, Inc. compensation from a third party: one hundred thousand free trading shares of stock in Pluristem Life Systems, Inc., already delivered from a third party. To date, MP has sold ninety five thousand shares of stock in Pluristem Life Systems, Inc. for proceeds totaling seventy six thousand dollars. MP's officers and directors reserve the right to buy additional shares of the company discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services.